Treatment in Milan (Italy)

Doctor Luca Aldrighetti is a highly experienced hepatobiliary surgeon and the Head of the Hepatobiliary and General Surgery Division at the San Raffaele Research Hospital in Milan. He is an international pioneer of minimally invasive liver surgery, having initiated and developed the San Raffaele laparoscopic liver resection program with more than 1,000 cases to date. He has a PhD in Technological Applications and Experimental Methodologies, is Professor at the Vita-Salute San Raffaele University and the IRCCS San Raffaele Hospital, and is a member of 18 national and international scientific societies.

Head of the Orthopedics Department, Orthopedic Surgeon

Prof. Carlo Pappone is the Head of the Operative Unit of Clinical Arithmology and the Electrophysiology Laboratory at IRCCS Policlinico San Donato in Milan and an experienced Fellow in numerous international cardiology societies. He has a specialization in Cardiology from 1990 and a PhD in Cardiovascular Diseases from 1995, and has been involved in all electrophysiology procedures. He has also developed a new epicardial ablation procedure to identify and eliminate the mechanisms that trigger sudden death in Brugada syndrome patients. He has been an invited speaker and moderator at major national and international congresses in the field of cardiology and arrhythmology, and has a total of 184 scientific articles, 30 book chapters and 184 papers with 16,814 citations and an H-Index of 50. He is also a reviewer of numerous journals and has won an Elite Reviewer Award from the Editorial Board of the Journal of the American College of Cardiology (JACC) in 2006.

Dr. Giorgia Mangili is the Head of the Medical Gynecological Oncology Group at the San Raffaele Scientific Institute Hospital since 2002. She has a degree in general medicine and specialties in gynecology and obstetrics, oncology, and is an Associate and Professor in obstetrics and gynecology. She focuses her work on gynaecological oncology, rare gynaecological tumours, preservation of fertility in oncology and cancer and pregnancy. She is a member of the European Organisation for Treatment of Trophoblastic Diseases, the European Society of Gynaecological Oncology, and the Italian Society of Gynecologic Oncology.

Dr. Jacopo Peccatori is the Head of Bone Marrow Transplant Department in San Raffaele Scientific Institute and one of the top lymphoma doctors. He has been in this position since 2006 and has written over 70 studies on allogeneic bone marrow transplantation, acute leukemia, and multiple myeloma. He has a degree in general medicine from the University of Milan and specialties in internal medicine and haematology and is a member of The European Society for Blood and Marrow Transplantation and The Italian Group for Hematopoietic Stem Cell Transplantation and Cell Therapies.

Dr. Francesco Bedogni is an Interventional Cardiologist at San Donato Hospital in Milan and a European proctor for TAVI and MITRACLIP. He is a board member of the Italian Society of Interventional Cardiology and is responsible for multiple clinical studies and position papers.

Professor Stefano Boriani is a world-renowned orthopedic surgeon and author of unique surgical staging system of spinal tumors and tumor resection techniques. He has performed over 3,000 surgical procedures, written over 430 research articles, and invented a carbon fiber system for tumor reconstruction. He is also a professor at the Post-Graduate School of Orthopaedics at the University of Bologna, and a honorary member of several spine societies. He is also the founder of a non-profit association in Mozambique which supports medical activities and trains local surgeons.

Prof. Luigi Massimo Zagra is the Head of the Hip Surgery Department I at the IRCCS Istituto Ortopedico Galeazzi in Milan.

He is the visiting professor at the School of Specialization in Orthopaedics and Traumatology of the University of Milan.

Prof. Zagra has performed more than 5,000 major orthopaedic operations.

Mainly focused on hip surgery including complex primary, revision (25% of cases), conservative surgery, osteotomies, and pediatric hip diseases arthroplasty.

He performs hip replacement surgery daily for osteoarthritis, particularly in cases of congenital dysplasia, developmental and post-traumatic malformations, rheumatoid arthritis, necrosis in young and old patients, needing special implants to prevent any possible complications. 

Dealing with problems with previously placed implants, in particular material wear and tear, such as in metal-on-metal or old-generation polyethylene prostheses, painful, loose, unstable, infected prostheses, using tissue-safe and non-invasive methods and the latest ceramic and titanium implants, including cemented ones.

He is currently Chairman of the Scientific Committee of the European Hip Society and the Italian Hip Society, as well as a member of the Executive Committee of EFORT, of International Committee of the American Association of Hip and Knee Surgeons and of the Scientific Committee of the Italian Arthroplasty Registry. 

He is author and co-author of 130 articles published in national and international journals, as well as invited specialist and speaker at over 500 congresses in Italy and abroad.

Dr. Andrés J.M. Ferreri is a medical oncologist with over 300 scientific papers published related to lymphoma treatment. He is a Deputy Director at the Hematology Oncology Department and Director of the Lymphoma Unit at the San Raffaele Scientific Institute, as well as Founder of the Italian Lymphoma Foundation. He is a member of various prestigious medical organizations and a Contract Professor of Oncology at the Università Vita-Salute San Raffaele.

Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.

Dr. Francesco Grecchi is a maxillofacial surgeon at the Maxillofacial Surgery Unit at the IRCCS Galeazzi Orthopedic Institute in Milan. He is specialized in General Surgery and Maxillofacial Surgery and is a founding member of GISOS with co-authorship of over 100 publications in national and international journals. He is also a Referent in Maxillofacial Surgery for the National Ectodermal Dysplasia Association and consultant of the Maxillofacial Surgery department of the Italian Stomatological Institute in Milan.